Delivery Order SPE2DB20D1109-SPE2DB22FP06A
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $17,599.91 firm-fixed-price delivery order is for the supply of 4562330199 - MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of September 28, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,934.27 Firm Fixed Price Delivery Order is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 8, 2023 and was awarded on December 7, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,923.95 firm-fixed-price delivery order, with a completion date of September 21, 2023, is for the pharmaceutical product MULTAQ 400 MG TABLET 60S. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award, valued at $3,219.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of MULTAQ 400 MG TABLET 60S. The contract has a completion date of February 6, 2024 and is a firm fixed-price delivery order. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,065.40 Firm Fixed Price Delivery Order covers the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 4, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $22,557.90 firm fixed-price delivery order is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 22, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,851.05 firm fixed-price delivery order is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of November 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of MULTAQ 400 MG TABLET 60S. The $5,798.82 firm-fixed-price delivery order has an ultimate completion date of September 28, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $15,081.17 for the supply of medical products, including the drug MULTAQ 400 MG TABLET 60S. The contract is with the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of May 2, 2023. The contract is a firm fixed-price arrangement and was awarded on May 1, 2023, with no set-aside designation. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $37,415.59 firm fixed-price delivery order is for the pharmaceutical product MULTAQ 400 MG TABLET 60S. The award has an ultimate completion date of January 16, 2024 and was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB22FP06ADelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,405.87 firm fixed-price delivery order is for the supply of MULTAQ 400 MG TABLET 60S, a medication used for cardiovascular health. The contract has an ultimate completion date of April 21, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has significant experience providing pharmaceutical products and medical supplies to the U.S. government. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for delivering a range of essential medications and medical commodities to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These contracting mechanisms enable efficient government procurement of critical pharmaceutical and medical supplies for the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 4/20/22 |